IRIS
RIONDINO, SILVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.361
EU - Europa 1.058
AS - Asia 655
SA - Sud America 10
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
AF - Africa 1
Totale 16.092
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.351
SG - Singapore 340
IT - Italia 185
UA - Ucraina 175
IE - Irlanda 170
CN - Cina 168
DE - Germania 117
PL - Polonia 105
RU - Federazione Russa 83
FR - Francia 80
KR - Corea 70
FI - Finlandia 53
GB - Regno Unito 40
HK - Hong Kong 26
ID - Indonesia 14
NL - Olanda 13
CA - Canada 10
BE - Belgio 8
IN - India 8
ES - Italia 7
CZ - Repubblica Ceca 6
JP - Giappone 6
EU - Europa 5
SA - Arabia Saudita 5
CH - Svizzera 4
CL - Cile 4
PH - Filippine 4
SE - Svezia 4
TR - Turchia 4
BR - Brasile 3
BD - Bangladesh 2
EC - Ecuador 2
LT - Lituania 2
RO - Romania 2
TW - Taiwan 2
VN - Vietnam 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BG - Bulgaria 1
BO - Bolivia 1
DK - Danimarca 1
EG - Egitto 1
KZ - Kazakistan 1
LU - Lussemburgo 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
TH - Thailandia 1
Totale 16.092
Salva come PNG Salva come JPEG
Città #
Woodbridge 4.134
Wilmington 3.702
Houston 3.576
Fairfield 452
Singapore 298
Chandler 297
Ann Arbor 296
Ashburn 222
Seattle 220
Cambridge 204
Dublin 144
Jacksonville 143
Kraków 105
Medford 103
New York 91
Rome 81
Santa Clara 75
Beijing 69
Dearborn 64
San Diego 59
Lawrence 49
Menlo Park 41
Hong Kong 26
Zhengzhou 24
Engelhard 20
Moscow 14
Jakarta 13
Helsinki 11
Milan 11
Los Angeles 10
Nanjing 10
Boardman 9
Detroit 9
Brussels 8
Council Bluffs 8
Creede 8
London 8
Shanghai 8
Norwalk 7
Verona 7
Brno 6
Kunming 6
Lappeenranta 6
Falls Church 5
Monte Vista 5
Mountain View 5
Redwood City 5
Barcelona 4
Fort Worth 4
Guangzhou 4
Hefei 4
Miami 4
Tokyo 4
Toronto 4
Anzio 3
Cedarhurst 3
Chaoyang 3
Hangzhou 3
Hounslow 3
Indiana 3
Manila 3
Nanchang 3
Nuremberg 3
Pataskala 3
Riyadh 3
Salt Lake City 3
San Jose 3
Xian 3
Bengaluru 2
Bitonto 2
Bristol 2
Busto Arsizio 2
Changchun 2
Chengdu 2
Del Norte 2
Dong Ket 2
Edmonton 2
Florence 2
Fremont 2
Giugliano in Campania 2
L’Aquila 2
Marino 2
Montreal 2
Mülheim 2
Noci 2
Palo Alto 2
Pune 2
Quito 2
Rostock 2
San Francisco 2
Seoul 2
Shenzhen 2
Taipei 2
The Dalles 2
Trento 2
Turin 2
Washington 2
Zhongshan 2
Absecon 1
Acton 1
Totale 14.806
Salva come PNG Salva come JPEG
Nome #
Sample PREanalytical Code for labeling of biospecimens: an analysis of specimen labeling protocols 460
Anti-angiogenic drugs, vascular toxicity and thromboembolism in solid cancer 435
Predictive value of high-sensitive D-dimer determination for chemotherapy-associated venous thromboembolism in gastrointestinal cancer patients 434
Ketogenic diet and other dietary intervention strategies in the treatment of cancer 427
Biological and predictive role of ERCC1 polymorphisms in cancer 420
Type 2 diabetes and breast cancer: The interplay between impaired glucose metabolism and oxidant stress 416
Venous thromboembolism risk prediction in ambulatory cancer patients: Clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio 415
Prognostic value of glycated hemoglobin in colorectal cancer 414
Clinical models and biochemical predictors of VTE in lung cancer 412
Functional impairment of activated protein C in breast cancer - relationship to survival outcomes 412
Gender differences in cancer-associated venous thromboembolism 412
Novel high-sensitive D-dimer determination predicts chemotherapy-associated venous thromboembolism in intermediate risk lung cancer patients 411
Oxidant stress as a major determinant of platelet activation in invasive breast cancer 411
RFID as a new ICT tool to monitor specimen life cycle and quality control in a biobank 410
Early changes of a novel APC-dependent thrombin generation assay during chemotherapy independently predict venous thromboembolism in cancer patients--a pilot study 407
RISK: A random optimization interactive system based on kernel learning for predicting breast cancer disease progression 407
Risk assessment for venous thromboembolism in chemotherapy treated ambulatory cancer patients: a machine learning approach 405
Obesity and colorectal cancer: role of adipokines in tumor initiation and progression 403
An activated protein C-dependent thrombin generation assay predicts chemotherapy-associated venous thromboembolism in cancer patients 400
Pretreatment Insulin Levels as a Prognostic Factor for Breast Cancer Progression 395
VEGF gene promoter polymorphisms and risk of VTE in chemotherapytreated cancer patients 386
VEGF and VTE risk in cancer patients-letter 384
Association between increased tumor necrosis factor alpha levels and acquired activated protein C resistance in patients with metastatic colorectal cancer 380
Ensuring Sample Quality for Biomarker Discovery Studies - Use of ICT Tools to Trace Biosample Life-cycle 380
Determinants of homocysteine levels in colorectal and breast cancer patients 379
Evaluation of mean platelet volume as a predictive marker for cancer-associated venous thromboembolism during chemotherapy 373
Neutrophil/lymphocyte ratio helps select metastatic pancreatic cancer patients benefitting from oxaliplatin 364
Predictive value of high-density lipoprotein (HDL)-cholesterol for cancer-associated venous thromboembolism during chemotherapy 360
Impact of chemotherapy on venous thromboembolism: comment to: regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis Study 358
Insulin resistance as a predictor of venous thromboembolism in breast cancer 354
Impact of VEGF gene polymorphisms in elderly cancer patients: Clinical outcome and toxicity 354
Estimated glomerular filtration rate is an easy predictor of venous thromboembolism in cancer patients undergoing platinum-based chemotherapy 348
Prognostic significance of serum adipokine levels in colorectal cancer patients 345
Impact of chemotherapy on activated protein C-dependent thrombin generation--association with VTE occurrence 343
Breast Cancer Prognosis Using a Machine Learning Approach 319
Validation of a machine learning approach for venous thromboembolism risk prediction in oncology 316
Plasma plasminogen activator inhibitor-1 (PAI-1) levels in breast cancer - relationship with clinical outcome 309
Clinical significance of glycemic parameters on venous thromboembolism risk preDiction in gastrointestinal cancer 288
SPRECware: software tools for Standard PREanalytical Code (SPREC) labeling - effective exchange and search of stored biospecimens 281
Precision medicine in the ageing world: The role of biospecimen sciences 264
Predicting VTE in cancer patients: Candidate biomarkers and risk assessment models 201
Irinotecan or oxaliplatin: which is the first move for the mate? 82
Venous Thromboembolism in Cancer Patients on Simultaneous and Palliative Care 74
Clinical utility of plasma KRAS, NRAS and BRAF mutational analysis with real time PCR in metastatic colorectal cancer patients -The importance of tissue/plasma discordant cases 70
Activity of ALK Inhibitors in Renal Cancer with ALK Alterations: A Systematic Review 50
Effects of rosuvastatin on platelet inhibition by clopidogrel in cardiovascular patients 48
Artificial Intelligence Predictive Models of Response to Cytotoxic Chemotherapy Alone or Combined to Targeted Therapy for Metastatic Colorectal Cancer Patients: A Systematic Review and Meta-Analysis 45
KRAS and BRAF Mutations in Stage II/III Colon Cancer: A Systematic Review and Meta-Analysis 42
Concordance of blood-based and normal tissue-based dihydropyrimidine dehydrogenase (DPYD) genotyping 41
HIF2α, Hepcidin and their crosstalk as tumour-promoting signalling 39
Immune Response in Vitamin D Deficient Metastatic Colorectal Cancer Patients: A Player That Should Be Considered for Targeted Vitamin D Supplementation 34
Obesity and Breast Cancer: Interaction or Interference with the Response to Therapy? 32
Irinotecan- vs. Oxaliplatin-Based Doublets in KRASG12C-Mutated Metastatic Colorectal Cancer-A Multicentre Propensity-Score-Matched Retrospective Analysis 32
MiRNAs and circRNAs for the Diagnosis of Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients: A Narrative Review 32
NTRK Gene Fusions in Solid Tumors and TRK Inhibitors: A Systematic Review of Case Reports and Case Series 30
Untailored vs. Gender- and Body-Mass-Index-Tailored Skeletal Muscle Mass Index (SMI) to Assess Sarcopenia in Advanced Head and Neck Squamous Cell Carcinoma (HNSCC) 28
Extracellular volume measured by whole body CT scans predicts chronic cardiotoxicity in breast cancer patients treated with neoadjuvant therapies based on anthracyclines: a retrospective study 26
Antibody-Drug Conjugates for the Treatment of Renal Cancer: A Scoping Review on Current Evidence and Clinical Perspectives 26
Gender differences in cancer-associated venous thromboembolism 26
Nutritional index for immune-checkpoint inhibitor in patients with metastatic gastro-esophageal junction/gastric cancer 24
Platelet function in health and disease: from molecular mechanisms, redox considerations to novel therapeutic opportunities 23
The Role of Histology-Agnostic Drugs in the Treatment of Metastatic Castration-Resistant Prostate Cancer 22
Biospecimen Digital Twins: Moving from a "High Quality" to a "Fit-for-Purpose" Concept in the Era of Omics Sciences 20
Evaluating Explainable Machine Learning Models for Clinicians 19
Effectiveness of Immunotherapy in Non-Small Cell Lung Cancer Patients with a Diagnosis of COPD: Is This a Hidden Prognosticator for Survival and a Risk Factor for Immune-Related Adverse Events? 17
Factor seven activating protease activity levels in women with recurrent pregnancy loss 14
Enhanced TNF alpha and oxidative stress in patients with heart failure: effect of TNF alpha on platelet O2- production 13
Drug recommendation ranking for personalized medicine using outcomes of retrospective cancer patients 9
PD-L1 thresholds predict efficacy of immune checkpoint inhibition in first-line treatment of advanced gastroesophageal adenocarcinoma. A systematic review and meta-analysis of seven phase III randomized trials 5
Case report: Metastatic melanoma derived from a somatic-type malignant transformation of a mediastinal teratoma treated with immune checkpoint inhibitors 1
Totale 16.316
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.573
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.573
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.864 0 0 0 0 0 0 333 341 361 304 243 282
2020/20212.348 245 282 223 286 289 251 323 222 51 58 92 26
2021/2022652 28 50 11 10 19 30 69 109 38 130 33 125
2022/2023731 73 66 11 86 97 163 48 68 58 7 29 25
2023/2024337 35 10 23 23 23 94 42 12 9 7 6 53
2024/2025798 45 365 147 109 43 88 1 0 0 0 0 0
Totale 16.316